-

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of AdaptHealth Corp. (AHCO) and Encourages Long-Term AHCO Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) on behalf of the Company’s long-term investors. The investigation seeks to determine whether the members of AdaptHealth’s board of directors violated the securities laws and/or breached their fiduciary duties in connection with alleged corporate misconduct.

Recently a securities fraud complaint was filed against AdaptHealth on behalf of certain investors who purchased shares of AdaptHealth’s common stock between November 8, 2019 and July 16, 2021. According to the complaint, during that time period AdaptHealth made a series of materially false and misleading statements to investors about the Company’s business, operations, prospects, and leadership.

As detailed in the complaint, on April 13, 2021, AdaptHealth disclosed that it had put its Co-CEO “on unpaid leave” after claiming that it had “learned that authorities in Denmark have formally charged [him] with alleged tax fraud arising from certain past private activity.” Following this news, AdaptHealth’s stock price fell $7.30 per share, or nearly 20% in value.

Subsequently, on July 19, 2021, Jehoshaphat Research published a report alleging that AdaptHealth’s organic revenue growth had stalled, and that the Company had intentionally inflated and obscured its organic revenue growth figures. Following the release of the Jehoshaphat Report, AdaptHealth’s stock price fell an additional $1.51 per share, or nearly 6% in value.

Current AdaptHealth shareholders who purchased or acquired shares of the Company’s common stock prior to January 1, 2020 are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/adapthealth-corp/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation, and has helped recover in excess of $150 million on behalf of victimized investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Kaskela Law LLC

NASDAQ:AHCO

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation into Fairness of $9.50 Per Share Global Business Travel Group (GBTG) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Kaskela Law is investigating the fairness of the recently announced buyout of Global Business Travel Group, Inc. (NYSE: GBTG) (“GBTG”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their GBTG shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, GBTG announced that it had agreed to go privat...

Kaskela Law LLC Announces Shareholder Investigation of Playtika Holding Corp. and Encourages Investors with Losses to Contact the Firm – PLTK

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating Playtika Holding Corp. (NASDAQ: PLTK) (“Playtika”) on behalf of the company’s investors. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/playtika-holding/ Since July 2025, shares of Playtika’s common stock have declined in value from a trading price of over $4.50 per share to a current price of less than $3.50 per share, a decline of over 22%...

Kaskela Law LLC Announces Investigation into Fairness of $16.50 Per Share Select Medical Holdings (SEM) Stockholder Buyout; Affected Investors are Encouraged to Contact the Firm to Protect Their Investment and Legal Rights

NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--Shareholder litigation law firm Kaskela Law is investigating the fairness of the recently announced buyout of Select Medical Holdings Corp. (NYSE: SEM) (“Select Medical”) shareholders to determine whether the transaction as structured provides investors with a sufficient price for their shares. Click here to register for additional information about this investigation: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced th...
Back to Newsroom